MUMBAI-based pharmaceutical giant Cipla has opened its Australian headquarters in Melbourne. Cipla is the world’s largest manufacturer of antiretroviral drugs for patients with HIV/AIDS and has a turnover of US$1.4 billion per annum and more than 20,000 employees worldwide. One of the first investments by the company in a regional office outside India, the local office was officially opened by Dr Amanda Caples, Executive Director, Science & Technology Programs on behalf of the Victorian Govt. “Through our local staff Cipla will provide superior service to existing customers, build its customer base and provide expert advice to our R&D department on requirements of the Australian medicines market for future product opportunities,” said Oskar Hakansson, Cipla Head – Australia & New Zealand. Hakansson is pictured right with Dr Caples opening the new Melbourne headquarters.
THE Australian Consensus Framework for Ethical Collaboration in the Healthcare Sector was launched in Tokyo last week, with 50 signatories including Pharmacy Guild of Australia, SHPA, ASMI, CMA, CHF, Medicines Australia and NPS Medicinewise.